Prime Medicine (PRME)

• Market cap: $671M
• 1 day: 4.79%
• 5 days: 5.38%
• 1 month: -39.81%
• 3 months: 14.81%
• 6 months: 177.61%
• Year to date: 24.41%
• 1 year: 17.35%
• 5 years: -75.8%
• 10 years: -75.8%
• Sector: Healthcare
• Industry: Biotechnology

About: Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology.

Employees: 214